A comparative clinical randomized trial of cernilton® efficacy and safety in patients with chronic abacterial prostatitis
- Authors: Apolikhin OI1, Alyaev Y.G1, Sivkov AV1, Vinarov AZ1, Oshchepkov VN1, Keshishev NG1, Bedretdinova DA1, Akhvlediani ND1, Apolikhin OI1, Alyaev Y.G1, Sivkov AV1, Vinarov AZ1, Oschepkov VN1, Keshishev NG1, Bedretdinova DA1, Akhvlediani ND1
-
Affiliations:
- Issue: No 1 (2010)
- Pages: 29-34
- Section: Articles
- URL: https://journals.eco-vector.com/1728-2985/article/view/277533
- ID: 277533
Cite item
Full Text
Abstract
About the authors
O I Apolikhin
Yu G Alyaev
A V Sivkov
A Z Vinarov
V N Oshchepkov
N G Keshishev
D A Bedretdinova
N D Akhvlediani
O I Apolikhin
Yu G Alyaev
A V Sivkov
A Z Vinarov
V N Oschepkov
N G Keshishev
D A Bedretdinova
N D Akhvlediani
References
- Krieger J. N., Ross S. O., Riley D. E. Chronic prostatitis: epidemiology and role of infection. Urology 2002; 60 (6, Suppl.): 8- 12; discus.: 13.
- McNaughton Collins M., Barry M. J. Epidemiology of chronic prostatitis. Curr. Opin. Urol. 1998; 8 (1): 33-37.
- Pontari M. A. Chronic prostatitis/chronic pelvic pain syndrome. Urol. Clin. N. Am. 2008; 35 (1): 81-89.
- Krieger J. N. Classification, epidemiology and implications of chronic prostatitis in North America, Europe and Asia. Minerva Urol. Nefrol. 2004; 56 (2): 99-107.
- Лопаткин Н. А. Руководство по урологии. М.; 1998.
- Jonsson K., Hedelin H. Chronic abacterial prostatitis: Living with a troublesome disease affecting many aspects of life. Scand. J. Urol. Nephrol. 2008; 1-6.
- Chiang P. H., Chiang C. P. Therapeutic effect of transurethral needle ablation in non-bacterial prostatitis: chronic pelvic pain syndrome type IIIa. Int. J. Urol. 2004; 11 (2): 97-102.
- Lu M. et al. Alpha-blockers and bioflavonoids in men with chronic non-bacterial prostatitis (NIH-IIIa): a prospective, placebo-controlled trial. Zhonghua Liu Xing Bing Xue Za Zhi 2004; 25 (2): 169-172.
- Nickel J. C. et al. A randomized placebo-controlled multicentre study to evaluate the safety and efficacy of finasteride for male chronic pelvic pain syndrome (category IIIA chronic nonbacterial prostatititis). Br. J. Urol. Int. 2004; 93 (7): 991-995.
- Nickel J. C. et al. Pentosan polysulfate therapy for chronic nonbacterial prostatitis (chronic pelvic pain syndrome category IIIA): a prospective maulticenter clinical trial. Urology 2000; 56 (3): 413-417.
- Schaeffer A. J. A randomized placebo-controlled multicentre study to evaluate the safety and efficacy of finasteride for male chronic pelvic pain syndrome (category IIIA chronic nonbacterial prostatitis). J. Urol. (Baltimore) 2005; 173 (3): 845.
- Wang W. et al. Effects of antibiotic and anti-inflammatory treatment on serum PSA and free PSA levels in patients with chronic prostatitis IIIA. Zhonghua Nan Ke Xue 2006; 12 (9): 787-790.
- Zeng X. et al. Clinical evaluation of celecoxib in treating type IIIA chronic prostatitis. Zhonghua Nan Ke Xue 2004; 10 (4): 278-281.
- Asakawa K. et al. Effects of cernitin pollen-extract (Cernilton) on inflammatory cytokines in sex-hormone-induced nonbacterial prostatitis rats. Hinyokika Kiyo 2001; 47 (7): 459-465.
- Leander G. Preliminary research on the therapeutic effect of Cernilton on chronic prostatovesiculitis. Sven. Lakartid. 1962; 59: 3296-3304.
- Aoki A. et al. Clinical evaluation of the effect of tamsulosin hydrochloride and cernitin pollen extract on urinary disturbance associated with benign prostatic hyperplasia in a multicentered study. Hinyokika Kiyo 2002; 48 (5): 259-267.
- Aslamazov E. G. et al. Cernilton in the treatment of prostatic adenoma and chronic prostatitis. Urologia 2007; 1: 52, 54-56.
- Dedhia R. C., McVary K. T. Phytotherapy for lower urinary tract symptoms secondary to benign prostatic hyperplasia. J. Urol. (Baltimore) 2008; 179 (6): 2119-2125.
- Kato T. et al. Clinical experience on treatment of chronic prostatitis with cernilton tablet. Hinyokika Kiyo 1970; 16 (4): 192- 195,
- Shaplygin L. V., Sivakov A. A. Use of cernilton in the therapy of prostatic adenoma and chronic prostatitits. Urologia 2007; 3: 35-37, 39.
- Talpur N. et al. Comparison of Saw Palmetto (extract and whole berry) and Cernitin on prostate growth in rats. Mol. Cell. Biochem. 2003; 250 (1-2): 21-26.
- Wilt T. et al. Cernilton for benign prostatic hyperplasia. Cochrane Database Syst. Rev. 2000; 2: CD001042.
- Xu J., Qian W. Q., Song J. D. A comparative study on different doses of cernilton for preventing the clinical progression of benign prostatic hyperplasia. Zhonghua Nan Ke Xue 2008; 14 (6): 533-537.